Accession Number: | 0001213900-19-019299 |
Date: | 2019-09-26 |
Issuer: | CORMEDIX INC. (CRMD) |
Original Submission Date: |
BALUCH KHOSO
C/O CORMEDIX INC.,
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS, NJ 07922
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-26 | 0 | $0.00 | 52,575 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 6.82 | 2019-09-26 | deemed execution date | A | 120,000 (a) | 2029-09-26 | common stock 120,000 | $6.82 | 120,000 | direct | ||
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 8.3 | 2019-09-26 | deemed execution date | 0 ( ) | 2029-01-10 | common stock 80,000 | $8.30 | 80,000 | direct | |||
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 12.6 | 2019-09-26 | deemed execution date | 0 ( ) | 2026-09-30 | common stock 250,000 | $12.60 | 250,000 | direct | |||
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 12.6 | 2019-09-26 | deemed execution date | 0 ( ) | 2026-09-30 | common stock 60,000 | $12.60 | 60,000 | direct |
ID | footnote |
---|---|
f1 | the options will vest over four (4) years in four (4) equal annual installments on the first four (4) anniversaries of september 26, 2019, provided, in all cases,that executive remains an employee of, or a consultant to, the company through the applicable vesting date. |
f2 | these options were granted on 1/10/2019. these options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25%vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievementof certain milestones. |
f3 | these options were granted 9/30/2016. the option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020. |
f4 | these options were granted 9/30/2016. the option vests based on certain performance milestones. if such milestones are met prior to 12/31/18, then theoption will not vest until 12/31/18. the option will be forfeited if such milestones are not met by 10/3/2020. |